ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1207

Clinical Relevance of Structural Measures in Knee Osteoarthritis: Baseline Values and Change from Baseline Discriminate Patients Subsequently Receiving Knee Replacement

C. Kent Kwoh1, Hans Guehring2, Michael J Hannon3 and Aida Aydemir4, 1University of Arizona Arthritis Center, Tuscan, AZ, 2Merck KGaA, Darmstadt, Germany, 3Medicine, University of Pittsburgh, Pittsburgh, PA, 4EMD Serono Research & Development Institute, Inc. (a business of Merck KGaA, Darmstadt, Germany), Billerica, MA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: DMOAD, Knee, Magnetic resonance imaging (MRI), osteoarthritis and x-ray

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Osteoarthritis – Clinical Aspects Poster I: Clinical Trials and Interventions

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Structural measures of knee OA (KOA) progression include assessment of radiographic joint space width (JSW) and quantitative MRI (qMRI) measurement of cartilage thickness, both of which are endpoints in clinical trials of Disease-modifying Osteoarthritis Drugs (DMOADs). Objectives were 1) to determine if baseline value and 2 year change of medial JSW, and medial and total femorotibial compartment cartilage thickness (MFTC, FTC), are discriminative of the risk of knee replacement (KR); and 2) to evaluate whether these associations differ by sex or Kellgren-Lawrence grade (KLG).

Methods: Osteoarthritis Initiative (OAI) knees were selected based on eligibility criteria typical of a DMOAD trials for KOA:  KLG of 2 or 3; medial minimum JSW (minJSW) ≥ 2.5 mm; knee pain at worst in the past 30 days from 4 to 9 on a 10-point scale, or 0 to 3 if pain medication was taken for joint pain; and availability of structural measures over two years. T-tests were used to look for differences in these measures by KR. Area under the receiver operating characteristic curve (AUC) was estimated for each measure using baseline and 2-year change values, in all patients as well as in male/female and in KLG=2/KLG=3 subgroups, to assess the ability of these measures to discriminate knees that went to future KR.  

Results: The sample included 627 participants, of which 107 underwent KR, with a median of 6.7 years of follow-up. The 2-year reductions from baseline in all imaging measures were significantly greater in participants who later underwent KR compared with those who did not [Table 1]. Among all participants, the ability of JSW and cartilage thickness to discriminate knees that had future KR was modest (max AUC=0.62); the best discrimination using baseline or 2 year change values was achieved with FTC. Among subgroups, AUCs for 2 year change tended to be numerically higher for males and KLG=2, and pronounced more for fJSW and FTC [Table 2].

Conclusion: 2-year changes in all image measures were important in discriminating knees that will undergo KR. Sex and KLG should be considered as factors in discrimination ability.

 

 


Disclosure: C. K. Kwoh, Pharmacy Benefits Manager, 5,Novartis and Astellas, 9,EMD Serono and Thusane, 9,NIH, EMD Serono, Abbvie, 2; H. Guehring, EMD Serono, Inc, 3; M. J. Hannon, EMD Serono, Inc, 5; A. Aydemir, EMD Serono, Inc, 3.

To cite this abstract in AMA style:

Kwoh CK, Guehring H, Hannon MJ, Aydemir A. Clinical Relevance of Structural Measures in Knee Osteoarthritis: Baseline Values and Change from Baseline Discriminate Patients Subsequently Receiving Knee Replacement [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/clinical-relevance-of-structural-measures-in-knee-osteoarthritis-baseline-values-and-change-from-baseline-discriminate-patients-subsequently-receiving-knee-replacement/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-relevance-of-structural-measures-in-knee-osteoarthritis-baseline-values-and-change-from-baseline-discriminate-patients-subsequently-receiving-knee-replacement/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology